AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-100 | >>
Results: 76-100/100
In vivo localization of [In-111]-DTPA-D-Phe(1)-octreotide to human ovariantumor xenografts tnduced to express the somatostatin receptor subtype 2 using an adenoviral vector
Authors: Rogers, BE McLean, SF Kirkman, RL Della Manna, D Bright, SJ Olsen, CC Myracle, AD Mayo, MS Curiel, DT Buchsbaum, DJ
Citation: Be. Rogers et al., In vivo localization of [In-111]-DTPA-D-Phe(1)-octreotide to human ovariantumor xenografts tnduced to express the somatostatin receptor subtype 2 using an adenoviral vector, CLIN CANC R, 5(2), 1999, pp. 383-393
Targeting strategies for cancer radiotherapy
Authors: Buchsbaum, DJ Rogers, BE Khazaeli, MB Mayo, MS Milenic, DE Kashmiri, SVS Anderson, CJ Chappell, LL Brechbiel, MW Curiel, DT
Citation: Dj. Buchsbaum et al., Targeting strategies for cancer radiotherapy, CLIN CANC R, 5(10), 1999, pp. 3048S-3055S
Interleukin-6 modulated conditionally replicative adenovirus as an antitumor/cytotoxic agent for cancer therapy
Authors: Rancourt, C Piche, A Gomez-Navarro, J Wang, MH Alvarez, RD Siegel, GP Fuller, GM Jones, SA Curiel, DT
Citation: C. Rancourt et al., Interleukin-6 modulated conditionally replicative adenovirus as an antitumor/cytotoxic agent for cancer therapy, CLIN CANC R, 5(1), 1999, pp. 43-50
Detection of coxsackie-adenovirus receptor (CAR) immunoreactivity in ovarian tumors of epithelial derivation
Authors: Khuu, H Conner, M Vanderkwaak, T Shultz, J Gomez-Navarro, J Alvarez, RD Curiel, DT Siegal, GP
Citation: H. Khuu et al., Detection of coxsackie-adenovirus receptor (CAR) immunoreactivity in ovarian tumors of epithelial derivation, APPL IMMUNO, 7(4), 1999, pp. 266-270
Considerations and challenges for the achievement of targeted gene delivery
Authors: Curiel, DT
Citation: Dt. Curiel, Considerations and challenges for the achievement of targeted gene delivery, GENE THER, 6(9), 1999, pp. 1497-1498
Tumor-specific gene transfer via an adenoviral vector targeted to the pan-carcinoma antigen EpCAM
Authors: Haisma, HJ Pinedo, HM van Rijswijk, A van der Muelen-Muileman, I Sosnowski, BA Ying, W van Beusechem, VW Tillman, BW Gerritsen, WR Curiel, DT
Citation: Hj. Haisma et al., Tumor-specific gene transfer via an adenoviral vector targeted to the pan-carcinoma antigen EpCAM, GENE THER, 6(8), 1999, pp. 1469-1474
Insertion of an RGD motif into the HI loop of adenovirus fiber protein alters the distribution of transgene expression of the systemically administered vector
Authors: Reynolds, PN Dimitriev, I Curiel, DT
Citation: Pn. Reynolds et al., Insertion of an RGD motif into the HI loop of adenovirus fiber protein alters the distribution of transgene expression of the systemically administered vector, GENE THER, 6(7), 1999, pp. 1336-1339
Gene therapy for cancer
Authors: Gomez-Navarro, J Curiel, DT Douglas, JT
Citation: J. Gomez-navarro et al., Gene therapy for cancer, EUR J CANC, 35(6), 1999, pp. 867-885
Gene therapy for cancer (Reprinted from Eur J Cancer, vol 35, pg 867-885, 1999)
Authors: Gomez-Navarro, J Curiel, DT Douglas, JT
Citation: J. Gomez-navarro et al., Gene therapy for cancer (Reprinted from Eur J Cancer, vol 35, pg 867-885, 1999), EUR J CANC, 35(14), 1999, pp. 2039-2057
Specific membrane receptor gene expression targeted with radiolabeled peptide employing the erbB-2 and DF3 promoter elements in adenoviral vectors
Authors: Stackhouse, MA Buchsbaum, DJ Kancharla, SR Grizzle, WE Grimes, C Laffoon, K Pederson, LC Curiel, DT
Citation: Ma. Stackhouse et al., Specific membrane receptor gene expression targeted with radiolabeled peptide employing the erbB-2 and DF3 promoter elements in adenoviral vectors, CANC GENE T, 6(3), 1999, pp. 209-219
Retargeting to EGFR enhances adenovirus infection efficiency of squamous cell carcinoma
Authors: Blackwell, JL Miller, CR Douglas, JT Li, H Reynolds, PN Carroll, WR Peters, GE Strong, TV Curiel, DT
Citation: Jl. Blackwell et al., Retargeting to EGFR enhances adenovirus infection efficiency of squamous cell carcinoma, ARCH OTOLAR, 125(8), 1999, pp. 856-863
DNA-based non-invasive vaccination onto the skin
Authors: Shi, ZK Curiel, DT Tang, DC
Citation: Zk. Shi et al., DNA-based non-invasive vaccination onto the skin, VACCINE, 17(17), 1999, pp. 2136-2141
An advanced generation of adenoviral vectors selectively enhances gene transfer for ovarian cancer gene therapy approaches
Authors: Vanderkwaak, TJ Wang, MH Gomez-Navarro, J Rancourt, C Dmitriev, I Krasnykh, V Barnes, M Siegal, GP Alvarez, R Curiel, DT
Citation: Tj. Vanderkwaak et al., An advanced generation of adenoviral vectors selectively enhances gene transfer for ovarian cancer gene therapy approaches, GYNECOL ONC, 74(2), 1999, pp. 227-234
Construction of a recombinant adenovirus vector encoding Fas ligand with aCRE/loxp inducible system
Authors: Bilbao, G Zhang, H Contreras, JL Zhou, T Feng, M Saito, I Mountz, JD Curiel, DT
Citation: G. Bilbao et al., Construction of a recombinant adenovirus vector encoding Fas ligand with aCRE/loxp inducible system, TRANSPLAN P, 31(1-2), 1999, pp. 792-793
Genetic cytoprotection of human endothelial cells during preservation timewith an adenoviral vector encoding the anti-apoptotic human Bcl-2 gene
Authors: Bilbao, G Contreras, JL Mikheeva, G Krasnykh, V Eckhoff, DE Thomas, FT Thomas, J Curiel, DT
Citation: G. Bilbao et al., Genetic cytoprotection of human endothelial cells during preservation timewith an adenoviral vector encoding the anti-apoptotic human Bcl-2 gene, TRANSPLAN P, 31(1-2), 1999, pp. 1012-1015
Genetic modification of liver grafts with an adenoviral vector encoding the Bcl-2 gene improves organ preservation
Authors: Bilbao, G Contreras, JL Gomez-Navarro, J Eckhoff, DE Mikheeva, G Krasnykh, V Hynes, T Thomas, FT Thomas, JM Curiel, DT
Citation: G. Bilbao et al., Genetic modification of liver grafts with an adenoviral vector encoding the Bcl-2 gene improves organ preservation, TRANSPLANT, 67(6), 1999, pp. 775-783
Adenovirus-mediated gene expression in vivo is enhanced by the antiapoptotic Bcl-2 gene
Authors: Bilbao, G Contreras, JL Zhang, HG Pike, MJ Overturf, K Mikheeva, G Krasnykh, V Curiel, DT
Citation: G. Bilbao et al., Adenovirus-mediated gene expression in vivo is enhanced by the antiapoptotic Bcl-2 gene, J VIROLOGY, 73(8), 1999, pp. 6992-7000
Maturation of dendritic cells accompanies high-efficiency gene transfer bya CD40-targeted adenoviral vector
Authors: Tillman, BW de Gruijl, TD Luykx-De Bakker, SA Scheper, RJ Pinedo, HM Curiel, TJ Gerritsen, WR Curiel, DT
Citation: Bw. Tillman et al., Maturation of dendritic cells accompanies high-efficiency gene transfer bya CD40-targeted adenoviral vector, J IMMUNOL, 162(11), 1999, pp. 6378-6383
Bcl-2 and Bcl-X-L serve an anti-inflammatory function in endothelial tellsthrough inhibition of NF-kappa B
Authors: Badrichani, AZ Stroka, DM Bilbao, G Curiel, DT Bach, FH Ferran, C
Citation: Az. Badrichani et al., Bcl-2 and Bcl-X-L serve an anti-inflammatory function in endothelial tellsthrough inhibition of NF-kappa B, J CLIN INV, 103(4), 1999, pp. 543-553
Gene therapy for gliomas: Molecular targets, adenoviral vectors, and oncolytic adenoviruses
Authors: Alemany, R Gomez-Manzano, C Balague, C Yung, WKA Curiel, DT Kyritsis, AP Fueyo, J
Citation: R. Alemany et al., Gene therapy for gliomas: Molecular targets, adenoviral vectors, and oncolytic adenoviruses, EXP CELL RE, 252(1), 1999, pp. 1-12
Fibroblast growth factor 2 retargeted adenovirus has redirected cellular tropism: Evidence for reduced toxicity and enhanced antitumor activity in mice
Authors: Gu, DL Gonzalez, AM Printz, MA Doukas, J Ying, WB D'Andrea, M Hoganson, DK Curiel, DT Douglas, JT Sosnowski, BA Baird, A Aukerman, SL Pierce, GF
Citation: Dl. Gu et al., Fibroblast growth factor 2 retargeted adenovirus has redirected cellular tropism: Evidence for reduced toxicity and enhanced antitumor activity in mice, CANCER RES, 59(11), 1999, pp. 2608-2614
Reduction of ischemia-reperfusion injury of the liver by in vivo adenovirus-mediated gene transfer of the antiapoptotic bcl-2 gene
Authors: Bilbao, G Contreras, JL Eckhoff, DE Mikheeva, G Krasnykh, V Douglas, JT Thomas, FT Thomas, JM Curiel, DT
Citation: G. Bilbao et al., Reduction of ischemia-reperfusion injury of the liver by in vivo adenovirus-mediated gene transfer of the antiapoptotic bcl-2 gene, ANN SURG, 230(2), 1999, pp. 185-193
High-efficacy thymidine kinase gene transfer to ovarian cancer cell lines mediated by herpes simplex virus type 1 vector
Authors: Wang, MH Rancourt, C Navarro, JG Krisky, D Marconi, P Oligino, T Alvarez, RD Siegal, GP Glorioso, JC Curiel, DT
Citation: Mh. Wang et al., High-efficacy thymidine kinase gene transfer to ovarian cancer cell lines mediated by herpes simplex virus type 1 vector, GYNECOL ONC, 71(2), 1998, pp. 278-287
Differential susceptibility of primary and established human glioma cells to adenovirus infection: Targeting via the epidermal growth factor receptorachieves fiber receptor-independent gene transfer
Authors: Miller, CR Buchsbaum, DJ Reynolds, PN Douglas, JT Gillespie, GY Mayo, MS Raben, D Curiel, DT
Citation: Cr. Miller et al., Differential susceptibility of primary and established human glioma cells to adenovirus infection: Targeting via the epidermal growth factor receptorachieves fiber receptor-independent gene transfer, CANCER RES, 58(24), 1998, pp. 5738-5748
Efficient gene delivery into Epstein-Barr virus (EBV)-transformed human B cells mediated by replication-defective herpes simplex virus-1 (HSV-1): A gene therapy model for EBV-related B cell malignancy
Authors: Suzuki, T Piche, A Kasono, K Xiang, JL Gomez-Navarro, J Moriuchi, S Krisky, DM Oligino, T Glorioso, JC Curiel, TJ Curiel, DT
Citation: T. Suzuki et al., Efficient gene delivery into Epstein-Barr virus (EBV)-transformed human B cells mediated by replication-defective herpes simplex virus-1 (HSV-1): A gene therapy model for EBV-related B cell malignancy, BIOC BIOP R, 252(3), 1998, pp. 686-690
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>